Navigation Links
IIVS Receives First Mark Twain Ethical Science Award for Successes In Replacing Animals for Chemical and Product Safety Testing
Date:6/30/2010

GAITHERSBURG, Md., June 30 /PRNewswire-USNewswire/ -- In recognition of its leadership in the optimization, validation and routine use of non-animal testing methods, The Institute for In Vitro Sciences (IIVS), Inc. has been awarded the first Mark Twain Ethical Science Award. This honor, presented by People for the Ethical Treatment of Animals (PETA), recognizes IIVS for its successes in helping hundreds of companies world-wide utilize testing strategies that minimize the use of animals, while at the same time maintain or improve the current level of safety for the public.

IIVS is a non-profit organization operating as a center of excellence for in vitro (non-animal) methods used for product safety testing purposes. IIVS's knowledge of the science and application of alternatives to animal experiments is recognized by regulatory agencies worldwide. It provides education and training for chemical and personal care product companies internationally, enabling them to successfully apply non-animal methods within their product testing programs. IIVS also performs testing services in their own quality controlled laboratories providing access to their expert scientific team on a contract basis.

"We are honored to be the first recipient of this prestigious award from PETA", said Dr Rodger Curren, President of IIVS. "Their continued support of our work to expand the application of non-animal methods for product testing has been extremely critical for many of our successes". As an example, Curren pointed out that PETA had recently provided partial funding for IIVS to participate in an international study for non-animal methods to detect skin irritants which resulted in the European Union accepting certain reconstructed human skin models for regulatory submissions. Curren added that an increasing number of scientists have found that the use of human artificial tissue constructs for product safety testing can provide much more accurate assessments of the potential risk to humans than testing in animals.

IIVS has worked for over thirteen years to advance the field of in vitro alternatives. The Mark Twain Ethical Science Award provides a clear demonstration of the impact of its work.

About IIVS

IIVS is a non-profit organization wholly dedicated to the promotion of rapid and innovative non-animal testing methods. Founded in 1997, IIVS is recognized as a leading provider of in vitro testing in support of toxicological safety evaluations. Rigorous scientific programs coupled with educational and outreach initiatives have established IIVS as a global leader in the advancement of alternatives to animal testing.

For more information please visit www.iivs.org


'/>"/>
SOURCE Institute for In Vitro Sciences
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
3. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
4. Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children
5. IsoTis Receives FDA Clearance for Accell Family of Products
6. Actavis Receives Approval of Fentanyl Transdermal System in the U.S.
7. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
8. IDM Pharma Receives Not Approvable Letter for Mifamurtide (L-MTP-PE) for the Treatment of Osteosarcoma
9. XTL Receives Staff Letter From NASDAQ
10. XTL Receives Staff Letter From NASDAQ; XTL may Transfer its ADR Listing to the NASDAQ Capital Market
11. Hemo-Stream(TM) Chronic Dialysis Catheter Receives FDA Clearance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the only free ... and will showcase its product’s latest features from June 26 to June 30, ... poster on Disrupting Clinical Trials in The Cloud during the conference. DIA ...
(Date:6/23/2016)... Windsor, Connecticut (PRWEB) , ... June 23, 2016 ... ... will introduce a new line of intelligent tools designed, tuned and optimized exclusively ... place September 12–17 in Chicago. The result of a collaboration among several companies ...
(Date:6/23/2016)... PUNE, India , June 23, 2016 /PRNewswire/ ... culture media market research report to its pharmaceuticals ... company profiles, product details and much more. ... market spread across 151 pages, profiling 15 companies ... now available at http://www.reportsnreports.com/reports/601420-global-cell-culture-media-industry-2016-market-research-report.html . ...
(Date:6/22/2016)... Research and Markets has announced the addition of the ... The global biomarkers market ... 2013. The market is expected to grow at a five-year compound ... from $50.6 billion in 2015 to $96.6 billion in 2020. ... (2015 to 2020) are discussed. As well, new products approved in ...
Breaking Biology Technology:
(Date:6/15/2016)... 15, 2016 Transparency Market ... Recognition Market by Application Market - Global Industry Analysis Size ... to the report, the  global gesture recognition market ... and is estimated to grow at a CAGR ... 2024.  Increasing application of gesture recognition ...
(Date:6/2/2016)... LONDON , June 2, 2016 ... has awarded the 44 million US Dollar project, ... Security Embossed Vehicle Plates including Personalization, Enrolment, and IT Infrastructure ... world leader in the production and implementation of Identity Management ... in January, however Decatur was selected ...
(Date:5/20/2016)...  VoiceIt is excited to announce its new ... By working together, VoiceIt and VoicePass will offer ... take slightly different approaches to voice biometrics, collaboration ... usability. Both ... "This marketing and technology partnership allows ...
Breaking Biology News(10 mins):